Skip to content

Troponin Elevation After Major Noncardiac Surgery 2

Clinical Characteristics and Functional Outcomes of Postoperative Myocardial Injury: A Prospective Cohort Study - Troponin Elevation After Major Noncardiac Surgery 2

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03408522
Acronym
TEAMS2
Enrollment
1000
Registered
2018-01-24
Start date
2018-01-29
Completion date
2019-12-31
Last updated
2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disability, Perioperative Myocardial Infarction, Perioperative/Postoperative Complications

Brief summary

Major adverse cardiac events (MACE) are a leading cause of mortality in patients undergoing noncardiac surgery. Patients with perioperative myocardial injury (PMI), defined as either myocardial infarction and lower elevations in cardiac troponin, are also at substantially increased risk of additional cardiac and noncardiac complications. Accordingly, it is plausible to assume that PMI negatively affects quality of life in terms of disability. The aim of this study is to investigate and compare the independent prognostic effects of the different PMI phenotypes (myocardial infarction and non-infarct troponin elevations) and noncardiac complications on disability in patients undergoing elective noncardiac surgery.

Interventions

None listed

Sponsors

University Health Network, Toronto
CollaboratorOTHER
UMC Utrecht
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 60 years old; * Major noncardiac surgery defined as all noncardiac surgical procedures requiring an expected hospital stay of at least 24 hours; * Elective surgery, defined as surgery that that has been preceded by a preoperative consultation at the anesthesia preoperative screening outpatient clinic.

Exclusion criteria

* Patients unable to fully comply to study needs (e.g. legally incapable patients or patients unable to communicate in Dutch or English). * Patients with an American Society of Anesthesiologists (ASA) Physical status 5

Design outcomes

Primary

MeasureTime frameDescription
Disability6 months after surgeryDisability is expressed by the World Health Organization Disability Assessment Score 2.0 (WHODAS 2.0), which is based on difficulties experienced by the respondent in different functional domains including, cognition, mobility, self-care, getting along, life activities and participation during the previous 30 days. Disability is defined as a decrement in each functioning domain corresponding to score between 0% and 100%, in which no disability stands for a score of 0% and full disability represents a score of 100%, including death.

Secondary

MeasureTime frameDescription
Disability free survival6 months after surgeryDisability free survival is defined as being alive with a WHODAS 2.0 score ≤ 25% and no increase of the pre-operative score ≥ 25% at 6 months after surgery.
Major adverse cardiovascular event (MACE)1 week after surgeryMACE is defined as a composite outcome consisting of cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, non-fatal ventricular fibrillation, ventricular arrhythmia with hemodynamic compromise, atrial fibrillation requiring cardioversion, pulmonary embolism, stroke
Noncardiac major adverse postoperative events (MAPE)1 week after surgeryNoncardiac MAPE is a composite outcome consisting of respiratory failure (including pneumonia and hypoxia or hypercapnia leading to ICU admission for respiratory support), sepsis, renal failure, unplanned ICU admission, unplanned medium care admission, reoperation
Length of hospital stay1 week after surgerythe number of days from the end of surgery until day of discharge
All-cause mortality1 week after surgery

Countries

Canada, Netherlands

Contacts

Primary ContactWilton A van Klei, MD, PhD
w.a.vanklei@umcutrecht.nl+3188 75 59475
Backup ContactLisette M Vernooij, Msc
l.m.vernooij@umcutrecht.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026